Niagen Bioscience, Inc. NAGE 54.01
Health Care · NASDAQ · Data as of 2026-06-29
Niagen Bioscience, Inc. (NAGE) has delivered +22.3% annualized revenue growth, n/a earnings growth, and n/a dividend growth over 10 years of data. Ranked #740 of 1993 stocks overall and #72 of 264 in the Health Care sector by Steady Score.
Industry
Medicinal Chemicals
Steady Score
54.01
Overall Rank
#740 / 1993
Sector Rank
#72 / 264
Revenue CAGR
+22.3%
Earnings CAGR
-
Dividend CAGR
-
?
E/R CAGR Ratio
-
Revenue
Earnings
Dividends
Free Cash Flow
Margin
NET Margin
FCF Margin
Payout Ratio
Payout Ratio
FCF Payout Ratio